-
1
-
-
40749109846
-
Paraneoplastic syndromes of the CNS
-
18339348 10.1016/S1474-4422(08)70060-7
-
Dalmau J, Rosenfeld MR. Paraneoplastic syndromes of the CNS. Lancet Neurol. 2008;7(4):327-40.
-
(2008)
Lancet Neurol
, vol.7
, Issue.4
, pp. 327-340
-
-
Dalmau, J.1
Rosenfeld, M.R.2
-
2
-
-
0033948619
-
Paraneoplastic limbic encephalitis: Neurological symptoms, immunological findings and tumour association in 50 patients
-
10869059 10.1093/brain/123.7.1481
-
Gultekin SH, Rosenfeld MR, Voltz R, Eichen J, Posner JB, Dalmau J. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain. 2000;123(Pt 7):1481-94.
-
(2000)
Brain
, vol.123
, Issue.PART 7
, pp. 1481-1494
-
-
Gultekin, S.H.1
Rosenfeld, M.R.2
Voltz, R.3
Eichen, J.4
Posner, J.B.5
Dalmau, J.6
-
3
-
-
0242349561
-
Clinical, magnetic resonance imaging, and electroencephalographic findings in paraneoplastic limbic encephalitis
-
14601695 10.4065/78.11.1363
-
Lawn ND, Westmoreland BF, Kiely MJ, Lennon VA, Vernino S. Clinical, magnetic resonance imaging, and electroencephalographic findings in paraneoplastic limbic encephalitis. Mayo Clin Proc. 2003;78(11):1363-8.
-
(2003)
Mayo Clin Proc
, vol.78
, Issue.11
, pp. 1363-1368
-
-
Lawn, N.D.1
Westmoreland, B.F.2
Kiely, M.J.3
Lennon, V.A.4
Vernino, S.5
-
4
-
-
43249123648
-
Role of FDG-PET in the clinical management of paraneoplastic neurological syndrome: Detection of the underlying malignancy and the brain PET-MRI correlates
-
18297363 10.1007/s11307-008-0134-7
-
Basu S, Alavi A. Role of FDG-PET in the clinical management of paraneoplastic neurological syndrome: detection of the underlying malignancy and the brain PET-MRI correlates. Mol Imaging Biol. 2008;10(3):131-7.
-
(2008)
Mol Imaging Biol
, vol.10
, Issue.3
, pp. 131-137
-
-
Basu, S.1
Alavi, A.2
-
5
-
-
10744229052
-
Potassium channel antibody-associated encephalopathy: A potentially immunotherapy-responsive form of limbic encephalitis
-
14960497
-
Vincent A, Buckley C, Schott JM, et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain. 2004;127(Pt 3):701-12.
-
(2004)
Brain
, vol.127
, Issue.PART 3
, pp. 701-712
-
-
Vincent, A.1
Buckley, C.2
Schott, J.M.3
-
6
-
-
77955338789
-
Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: A case series
-
20580615 10.1016/S1474-4422(10)70137-X 1:CAS:528:DC%2BC3cXpsFelsbw%3D Identification of the antigen in limbic encephalitis previously attributed to voltage-gated potassium channel antibodies
-
Lai M, Huijbers MG, Lancaster E, et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol. 2010;9(8):776-85. Identification of the antigen in limbic encephalitis previously attributed to voltage-gated potassium channel antibodies.
-
(2010)
Lancet Neurol
, vol.9
, Issue.8
, pp. 776-785
-
-
Lai, M.1
Huijbers, M.G.2
Lancaster, E.3
-
7
-
-
0030924896
-
Limbic encephalitis and small cell lung cancer. Clinical and immunological features
-
9217677 10.1093/brain/120.6.923
-
Alamowitch S, Graus F, Uchuya M, Rene R, Bescansa E, Delattre JY. Limbic encephalitis and small cell lung cancer. Clinical and immunological features. Brain. 1997;120(Pt 6):923-8.
-
(1997)
Brain
, vol.120
, Issue.PART 6
, pp. 923-928
-
-
Alamowitch, S.1
Graus, F.2
Uchuya, M.3
Rene, R.4
Bescansa, E.5
Delattre, J.Y.6
-
8
-
-
33947725313
-
Autoimmune limbic encephalitis in 39 patients: Immunophenotypes and outcomes
-
16980333 10.1136/jnnp.2006.100644 1:STN:280:DC%2BD2s7msFWktQ%3D%3D
-
Bataller L, Kleopa KA, Wu GF, Rossi JE, Rosenfeld MR, Dalmau J. Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes. J Neurol Neurosurg Psychiatry. 2007;78(4):381-5.
-
(2007)
J Neurol Neurosurg Psychiatry
, vol.78
, Issue.4
, pp. 381-385
-
-
Bataller, L.1
Kleopa, K.A.2
Wu, G.F.3
Rossi, J.E.4
Rosenfeld, M.R.5
Dalmau, J.6
-
9
-
-
79952412166
-
GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders
-
21357831 10.1212/WNL.0b013e31820e7b8d 1:CAS:528:DC%2BC3MXisFWqu78%3D A study clarifying that most cases of paraneoplastic limbic encephalitis associated with small cell lung cancer previously thought to be seronegative have in fact antibodies against the GABA-B receptor
-
Boronat A, Sabater L, Saiz A, Dalmau J, Graus F. GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders. Neurology. 2011;76(9):795-800. A study clarifying that most cases of paraneoplastic limbic encephalitis associated with small cell lung cancer previously thought to be seronegative have in fact antibodies against the GABA-B receptor.
-
(2011)
Neurology
, vol.76
, Issue.9
, pp. 795-800
-
-
Boronat, A.1
Sabater, L.2
Saiz, A.3
Dalmau, J.4
Graus, F.5
-
10
-
-
65649130790
-
AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location
-
19338055 10.1002/ana.21589 1:CAS:528:DC%2BD1MXmtVylsLc%3D
-
Lai M, Hughes EG, Peng X, et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol. 2009;65(4):424-34.
-
(2009)
Ann Neurol
, vol.65
, Issue.4
, pp. 424-434
-
-
Lai, M.1
Hughes, E.G.2
Peng, X.3
-
11
-
-
82955210356
-
Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome
-
22013185 10.1212/WNL.0b013e3182364a44 1:CAS:528:DC%2BC3MXhtl2qsLjK Identification of cell-membrane antibodies against mGluR5 in patients with paraneoplastic limbic encephalitis associated with Hodgkin disease
-
Lancaster E, Martinez-Hernandez E, Titulaer MJ, et al. Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome. Neurology. 2011;77(18):1698-701. Identification of cell-membrane antibodies against mGluR5 in patients with paraneoplastic limbic encephalitis associated with Hodgkin disease.
-
(2011)
Neurology
, vol.77
, Issue.18
, pp. 1698-1701
-
-
Lancaster, E.1
Martinez-Hernandez, E.2
Titulaer, M.J.3
-
12
-
-
33846809197
-
Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma
-
17262855 10.1002/ana.21050 1:CAS:528:DC%2BD2sXitlyjt7o%3D
-
Dalmau J, Tuzun E, Wu HY, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61(1):25-36.
-
(2007)
Ann Neurol
, vol.61
, Issue.1
, pp. 25-36
-
-
Dalmau, J.1
Tuzun, E.2
Wu, H.Y.3
-
13
-
-
55549135314
-
Anti-NMDA-receptor encephalitis: Case series and analysis of the effects of antibodies
-
18851928 10.1016/S1474-4422(08)70224-2 1:CAS:528:DC%2BD1cXhsFCrsLrF
-
Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008;7(12):1091-8.
-
(2008)
Lancet Neurol
, vol.7
, Issue.12
, pp. 1091-1098
-
-
Dalmau, J.1
Gleichman, A.J.2
Hughes, E.G.3
-
14
-
-
78649445081
-
Causes of encephalitis and differences in their clinical presentations in England: A multicentre, population-based prospective study
-
20952256 10.1016/S1473-3099(10)70222-X
-
Granerod J, Ambrose HE, Davies NW, et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis. 2010;10(12):835-44.
-
(2010)
Lancet Infect Dis
, vol.10
, Issue.12
, pp. 835-844
-
-
Granerod, J.1
Ambrose, H.E.2
Davies, N.W.3
-
15
-
-
84858117151
-
The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project
-
22281844 10.1093/cid/cir1038 1:CAS:528:DC%2BC38XktVGmtr8%3D
-
Gable MS, Sheriff H, Dalmau J, Tilley DH, Glaser CA. The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clin Infect Dis. 2012;54(7):899-904.
-
(2012)
Clin Infect Dis
, vol.54
, Issue.7
, pp. 899-904
-
-
Gable, M.S.1
Sheriff, H.2
Dalmau, J.3
Tilley, D.H.4
Glaser, C.A.5
-
16
-
-
33750955121
-
Clinical and immunological diversity of limbic encephalitis: A model for paraneoplastic neurologic disorders
-
17113466 10.1016/j.hoc.2006.09.011
-
Dalmau J, Bataller L. Clinical and immunological diversity of limbic encephalitis: a model for paraneoplastic neurologic disorders. Hematol Oncol Clin North Am. 2006;20(6):1319-35.
-
(2006)
Hematol Oncol Clin North Am
, vol.20
, Issue.6
, pp. 1319-1335
-
-
Dalmau, J.1
Bataller, L.2
-
17
-
-
25144485343
-
Neurosyphilis and paraneoplastic limbic encephalitis: Important differential diagnoses
-
15789128 10.1007/s00415-005-0812-1 1:STN:280:DC%2BD2MvpslynsA%3D%3D
-
Scheid R, Voltz R, Vetter T, Sabri O, von Cramon DY. Neurosyphilis and paraneoplastic limbic encephalitis: important differential diagnoses. J Neurol. 2005;252(9):1129-32.
-
(2005)
J Neurol
, vol.252
, Issue.9
, pp. 1129-1132
-
-
Scheid, R.1
Voltz, R.2
Vetter, T.3
Sabri, O.4
Von Cramon, D.Y.5
-
18
-
-
0034754087
-
Human herpesvirus 6 limbic encephalitis after stem cell transplantation
-
11706967 10.1002/ana.1251 1:STN:280:DC%2BD3MnlsVertg%3D%3D
-
Wainwright MS, Martin PL, Morse RP, et al. Human herpesvirus 6 limbic encephalitis after stem cell transplantation. Ann Neurol. 2001;50(5):612-9.
-
(2001)
Ann Neurol
, vol.50
, Issue.5
, pp. 612-619
-
-
Wainwright, M.S.1
Martin, P.L.2
Morse, R.P.3
-
19
-
-
78649995149
-
Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis
-
21163445 10.1016/S1474-4422(10)70253-2 1:CAS:528:DC%2BC3cXhsFCru7nE A thorough description of NMDAR-encephalitis, including epidemiological aspects, clinical features, diagnostic tests, response to treatment and outcome by the group that identified the antibodies and has the greatest experience with the condition
-
Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011;10(1):63-74. A thorough description of NMDAR-encephalitis, including epidemiological aspects, clinical features, diagnostic tests, response to treatment and outcome by the group that identified the antibodies and has the greatest experience with the condition.
-
(2011)
Lancet Neurol
, vol.10
, Issue.1
, pp. 63-74
-
-
Dalmau, J.1
Lancaster, E.2
Martinez-Hernandez, E.3
Rosenfeld, M.R.4
Balice-Gordon, R.5
-
20
-
-
0038796249
-
Herpes simplex encephalitis relapses in children: Differentiation of two neurologic entities
-
12874408 10.1212/01.WNL.0000073985.71759.7C
-
De Tiege X, Rozenberg F, Des Portes V, et al. Herpes simplex encephalitis relapses in children: differentiation of two neurologic entities. Neurology. 2003;61(2):241-3.
-
(2003)
Neurology
, vol.61
, Issue.2
, pp. 241-243
-
-
De Tiege, X.1
Rozenberg, F.2
Des Portes, V.3
-
21
-
-
84884211415
-
Pediatric anti-NMDAR encephalitis: Clinical analysis and novel findings in a series of 20 patients
-
10.1016/j.jpeds.2012.10.011
-
Armangue T, Titulaer MJ, Malaga I, et al. Pediatric anti-NMDAR encephalitis: clinical analysis and novel findings in a series of 20 patients. J Pediatr 2012. 10.1016/j.jpeds.2012.10.011
-
(2012)
J Pediatr
-
-
Armangue, T.1
Titulaer, M.J.2
Malaga, I.3
-
22
-
-
84871941545
-
-
10.1002/ana.23689.Up to 30 % of patients with herpes simplex virus encephalitis may develop autoimmunity associated with NMDA receptor antibodies
-
Prüss H, Finke C, Höltje M, et al. NMDA receptor antibodies in herpes simplex encephalitis. 2012. 10.1002/ana.23689.Up to 30 % of patients with herpes simplex virus encephalitis may develop autoimmunity associated with NMDA receptor antibodies
-
(2012)
NMDA Receptor Antibodies in Herpes Simplex Encephalitis
-
-
Prüss, H.1
Finke, C.2
Höltje, M.3
-
23
-
-
84860919278
-
Prevalence and immunological spectrum of temporal lobe epilepsy with glutamic acid decarboxylase antibodies
-
22353320 10.1111/j.1468-1331.2011.03609.x 1:STN:280: DC%2BC38vjslOnsw%3D%3D
-
Falip M, Carreno M, Miro J, et al. Prevalence and immunological spectrum of temporal lobe epilepsy with glutamic acid decarboxylase antibodies. Eur J Neurol. 2012;19(6):827-33.
-
(2012)
Eur J Neurol
, vol.19
, Issue.6
, pp. 827-833
-
-
Falip, M.1
Carreno, M.2
Miro, J.3
-
24
-
-
47549084584
-
Non-paraneoplastic limbic encephalitis associated with anti-glutamic acid decarboxylase antibodies
-
18586329 10.1016/j.jneuroim.2008.05.015 1:CAS:528:DC%2BD1cXptVWqtro%3D
-
Mata S, Muscas GC, Naldi I, et al. Non-paraneoplastic limbic encephalitis associated with anti-glutamic acid decarboxylase antibodies. J Neuroimmunol. 2008;199(1-2):155-9.
-
(2008)
J Neuroimmunol
, vol.199
, Issue.1-2
, pp. 155-159
-
-
Mata, S.1
Muscas, G.C.2
Naldi, I.3
-
25
-
-
0041842407
-
Paraneoplastic neurologic syndromes: Approaches to diagnosis and treatment
-
12894387 10.1055/s-2003-41134
-
Bataller L, Dalmau J. Paraneoplastic neurologic syndromes: approaches to diagnosis and treatment. Semin Neurol. 2003;23(2):215-24.
-
(2003)
Semin Neurol
, vol.23
, Issue.2
, pp. 215-224
-
-
Bataller, L.1
Dalmau, J.2
-
26
-
-
78650145089
-
Screening for tumours in paraneoplastic syndromes: Report of an EFNS task force
-
20880069 10.1111/j.1468-1331.2010.03220.x 1:STN:280: DC%2BC3M%2Fntleiuw%3D%3D
-
Titulaer MJ, Soffietti R, Dalmau J, et al. Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. Eur J Neurol. 2011;18(1):19-e13.
-
(2011)
Eur J Neurol
, vol.18
, Issue.1
-
-
Titulaer, M.J.1
Soffietti, R.2
Dalmau, J.3
-
27
-
-
0034981452
-
Anti-Hu-associated paraneoplastic encephalomyelitis: Analysis of 200 patients
-
11353730 10.1093/brain/124.6.1138 1:STN:280:DC%2BD3MzktFOlug%3D%3D
-
Graus F, Keime-Guibert F, Rene R, et al. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain. 2001;124(Pt 6):1138-48.
-
(2001)
Brain
, vol.124
, Issue.PART 6
, pp. 1138-1148
-
-
Graus, F.1
Keime-Guibert, F.2
Rene, R.3
-
28
-
-
0034060095
-
Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone
-
10727484 10.1136/jnnp.68.4.479 1:STN:280:DC%2BD3c7ptlOhsw%3D%3D
-
Keime-Guibert F, Graus F, Fleury A, et al. Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone. J Neurol Neurosurg Psychiatry. 2000;68(4):479-82.
-
(2000)
J Neurol Neurosurg Psychiatry
, vol.68
, Issue.4
, pp. 479-482
-
-
Keime-Guibert, F.1
Graus, F.2
Fleury, A.3
-
29
-
-
0942277092
-
Immunomodulatory treatment trial for paraneoplastic neurological disorders
-
14769141 10.1215/S1152851703000395
-
Vernino S, O'Neill BP, Marks RS, O'Fallon JR, Kimmel DW. Immunomodulatory treatment trial for paraneoplastic neurological disorders. Neuro Oncol. 2004;6(1):55-62.
-
(2004)
Neuro Oncol
, vol.6
, Issue.1
, pp. 55-62
-
-
Vernino, S.1
O'Neill, B.P.2
Marks, R.S.3
O'Fallon, J.R.4
Kimmel, D.W.5
-
30
-
-
31544438003
-
An uncontrolled trial of rituximab for antibody associated paraneoplastic neurological syndromes
-
16444604 10.1007/s00415-005-0882-0
-
Shams'ili S, de Beukelaar J, Gratama JW, et al. An uncontrolled trial of rituximab for antibody associated paraneoplastic neurological syndromes. J Neurol. 2006;253(1):16-20.
-
(2006)
J Neurol
, vol.253
, Issue.1
, pp. 16-20
-
-
Shams'Ili, S.1
De Beukelaar, J.2
Gratama, J.W.3
-
31
-
-
0032966523
-
Epilepsia partialis continua: A new manifestation of anti-Hu-associated paraneoplastic encephalomyelitis
-
9989630 10.1002/1531-8249(199902)45:2<255: AID-ANA18>3.0.CO;2-N 1:STN:280:DyaK1M7kt1OgtA%3D%3D
-
Shavit YB, Graus F, Probst A, Rene R, Steck AJ. Epilepsia partialis continua: a new manifestation of anti-Hu-associated paraneoplastic encephalomyelitis. Ann Neurol. 1999;45(2):255-8.
-
(1999)
Ann Neurol
, vol.45
, Issue.2
, pp. 255-258
-
-
Shavit, Y.B.1
Graus, F.2
Probst, A.3
Rene, R.4
Steck, A.J.5
-
32
-
-
4043101943
-
Clinical analysis of anti-Ma2-associated encephalitis
-
15215214 10.1093/brain/awh203
-
Dalmau J, Graus F, Villarejo A, et al. Clinical analysis of anti-Ma2-associated encephalitis. Brain. 2004;127(Pt 8):1831-44.
-
(2004)
Brain
, vol.127
, Issue.PART 8
, pp. 1831-1844
-
-
Dalmau, J.1
Graus, F.2
Villarejo, A.3
-
33
-
-
34147134976
-
Orchiectomy for suspected microscopic tumor in patients with anti-Ma2-associated encephalitis
-
17151337 10.1212/01.wnl.0000252379.81933.80 1:STN:280: DC%2BD2s7mvFOisw%3D%3D
-
Mathew RM, Vandenberghe R, Garcia-Merino A, et al. Orchiectomy for suspected microscopic tumor in patients with anti-Ma2-associated encephalitis. Neurology. 2007;68(12):900-5.
-
(2007)
Neurology
, vol.68
, Issue.12
, pp. 900-905
-
-
Mathew, R.M.1
Vandenberghe, R.2
Garcia-Merino, A.3
-
34
-
-
21844465114
-
Amphiphysin autoimmunity: Paraneoplastic accompaniments
-
15984030 10.1002/ana.20529
-
Pittock SJ, Lucchinetti CF, Parisi JE, et al. Amphiphysin autoimmunity: paraneoplastic accompaniments. Ann Neurol. 2005;58(1):96-107.
-
(2005)
Ann Neurol
, vol.58
, Issue.1
, pp. 96-107
-
-
Pittock, S.J.1
Lucchinetti, C.F.2
Parisi, J.E.3
-
35
-
-
0029790169
-
Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes
-
8795598 10.1136/jnnp.61.3.270 1:STN:280:DyaK28zovVWqtQ%3D%3D
-
Honnorat J, Antoine JC, Derrington E, Aguera M, Belin MF. Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 1996;61(3):270-8.
-
(1996)
J Neurol Neurosurg Psychiatry
, vol.61
, Issue.3
, pp. 270-278
-
-
Honnorat, J.1
Antoine, J.C.2
Derrington, E.3
Aguera, M.4
Belin, M.F.5
-
36
-
-
84865465580
-
Case records of the Massachusetts General Hospital. Case 27-2012. A 60-year-old woman with painful muscle spasms and hyperreflexia
-
22931320 10.1056/NEJMcpc1114036 1:CAS:528:DC%2BC38XhtlGktLvI
-
Byrne TN, Isakoff SJ, Rincon SP, Gudewicz TM. Case records of the Massachusetts General Hospital. Case 27-2012. A 60-year-old woman with painful muscle spasms and hyperreflexia. N Engl J Med. 2012;367(9):851-61.
-
(2012)
N Engl J Med
, vol.367
, Issue.9
, pp. 851-861
-
-
Byrne, T.N.1
Isakoff, S.J.2
Rincon, S.P.3
Gudewicz, T.M.4
-
37
-
-
79954604462
-
Tonic seizures: A diagnostic clue of anti-LGI1 encephalitis?
-
21482953 10.1212/WNL.0b013e3182152808
-
Andrade DM, Tai P, Dalmau J, Wennberg R. Tonic seizures: a diagnostic clue of anti-LGI1 encephalitis? Neurology. 2011;76(15):1355-7.
-
(2011)
Neurology
, vol.76
, Issue.15
, pp. 1355-1357
-
-
Andrade, D.M.1
Tai, P.2
Dalmau, J.3
Wennberg, R.4
-
38
-
-
29944443559
-
Rapid eye movement sleep behavior disorder and potassium channel antibody-associated limbic encephalitis
-
16278841 10.1002/ana.20693
-
Iranzo A, Graus F, Clover L, et al. Rapid eye movement sleep behavior disorder and potassium channel antibody-associated limbic encephalitis. Ann Neurol. 2006;59(1):178-81.
-
(2006)
Ann Neurol
, vol.59
, Issue.1
, pp. 178-181
-
-
Iranzo, A.1
Graus, F.2
Clover, L.3
-
39
-
-
79955422946
-
Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis
-
21416487 10.1002/ana.22307
-
Irani SR, Michell AW, Lang B, et al. Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol. 2011;69(5):892-900.
-
(2011)
Ann Neurol
, vol.69
, Issue.5
, pp. 892-900
-
-
Irani, S.R.1
Michell, A.W.2
Lang, B.3
-
40
-
-
77956378343
-
Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia
-
20663977 10.1093/brain/awq213
-
Irani SR, Alexander S, Waters P, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain. 2010;133(9):2734-48.
-
(2010)
Brain
, vol.133
, Issue.9
, pp. 2734-2748
-
-
Irani, S.R.1
Alexander, S.2
Waters, P.3
-
41
-
-
0141870049
-
Voltage-gated potassium channel antibodies in limbic encephalitis
-
14520669 10.1002/ana.10713 1:CAS:528:DC%2BD3sXosFCksb4%3D
-
Pozo-Rosich P, Clover L, Saiz A, Vincent A, Graus F. Voltage-gated potassium channel antibodies in limbic encephalitis. Ann Neurol. 2003;54(4):530-3.
-
(2003)
Ann Neurol
, vol.54
, Issue.4
, pp. 530-533
-
-
Pozo-Rosich, P.1
Clover, L.2
Saiz, A.3
Vincent, A.4
Graus, F.5
-
42
-
-
1842423491
-
Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody
-
15079019 10.1212/01.WNL.0000122648.19196.02 1:STN:280: DC%2BD2c7otlGmsQ%3D%3D
-
Thieben MJ, Lennon VA, Boeve BF, Aksamit AJ, Keegan M, Vernino S. Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology. 2004;62(7):1177-82.
-
(2004)
Neurology
, vol.62
, Issue.7
, pp. 1177-1182
-
-
Thieben, M.J.1
Lennon, V.A.2
Boeve, B.F.3
Aksamit, A.J.4
Keegan, M.5
Vernino, S.6
-
43
-
-
77951740941
-
Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis
-
20437582 10.1002/ana.21917 A study of patients with limbic encephalitis identifying a subgroup characterized by predominant seizures and associated anti-GAD antibodies, often evolving into refractory epilepsy despite treatment, and comparing outcome with those with VGKC-antibodies (now LGI1-antibodies)
-
Malter MP, Helmstaedter C, Urbach H, Vincent A, Bien CG. Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Ann Neurol. 2010;67(4):470-8. A study of patients with limbic encephalitis identifying a subgroup characterized by predominant seizures and associated anti-GAD antibodies, often evolving into refractory epilepsy despite treatment, and comparing outcome with those with VGKC-antibodies (now LGI1-antibodies).
-
(2010)
Ann Neurol
, vol.67
, Issue.4
, pp. 470-478
-
-
Malter, M.P.1
Helmstaedter, C.2
Urbach, H.3
Vincent, A.4
Bien, C.G.5
-
44
-
-
80955124576
-
Case records of the Massachusetts General Hospital. Case 34-2011: A 75-year-old man with memory loss and partial seizures
-
22070480 10.1056/NEJMcpc1100924 1:CAS:528:DC%2BC3MXhsF2gs77O
-
Cash SS, Larvie M, Dalmau J. Case records of the Massachusetts General Hospital. Case 34-2011: A 75-year-old man with memory loss and partial seizures. N Engl J Med. 2011;365(19):1825-33.
-
(2011)
N Engl J Med
, vol.365
, Issue.19
, pp. 1825-1833
-
-
Cash, S.S.1
Larvie, M.2
Dalmau, J.3
-
45
-
-
79952528976
-
Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia
-
21387375 10.1002/ana.22297 1:CAS:528:DC%2BC3MXktl2lsLo%3D
-
Lancaster E, Huijbers MG, Bar V, et al. Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Ann Neurol. 2011;69(2):303-11.
-
(2011)
Ann Neurol
, vol.69
, Issue.2
, pp. 303-311
-
-
Lancaster, E.1
Huijbers, M.G.2
Bar, V.3
-
46
-
-
84857995286
-
Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia
-
22338029 10.1136/jnnp-2011-301506
-
Becker EB, Zuliani L, Pettingill R, et al. Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia. J Neurol Neurosurg Psychiatry. 2012;83(4):437-40.
-
(2012)
J Neurol Neurosurg Psychiatry
, vol.83
, Issue.4
, pp. 437-440
-
-
Becker, E.B.1
Zuliani, L.2
Pettingill, R.3
-
47
-
-
84865583106
-
Morvan syndrome: Clinical and serological observations in 29 cases
-
22473710 10.1002/ana.23577
-
Irani SR, Pettingill P, Kleopa KA, et al. Morvan syndrome: clinical and serological observations in 29 cases. Ann Neurol. 2012;72(2):241-55.
-
(2012)
Ann Neurol
, vol.72
, Issue.2
, pp. 241-255
-
-
Irani, S.R.1
Pettingill, P.2
Kleopa, K.A.3
-
48
-
-
84872220267
-
Clinical features, treatment and outcome of 500 patients with anti-NMDA receptor encephalitis
-
10.1212/WNL.78.1-MeetingAbstracts.PL01.001 This multicenter study with more than 500 patients and independent outcome assessment provides important information regarding outcome, risk of relapses and treatment strategy for NMDAR-encephalitis
-
Titulaer MJ, McCracken L, Gabilondo I, et al. Clinical features, treatment and outcome of 500 patients with anti-NMDA receptor encephalitis. Neurology. 2012;78:PL01.001. This multicenter study with more than 500 patients and independent outcome assessment provides important information regarding outcome, risk of relapses and treatment strategy for NMDAR-encephalitis.
-
(2012)
Neurology
, vol.78
, pp. 01001
-
-
Titulaer, M.J.1
McCracken, L.2
Gabilondo, I.3
-
49
-
-
79952632728
-
Isolated hemidystonia associated with NMDA receptor antibodies
-
21412839 10.1002/mds.23315
-
Rubio-Agusti I, Dalmau J, Sevilla T, Burgal M, Beltran E, Bataller L. Isolated hemidystonia associated with NMDA receptor antibodies. Mov Disord. 2011;26(2):351-2.
-
(2011)
Mov Disord
, vol.26
, Issue.2
, pp. 351-352
-
-
Rubio-Agusti, I.1
Dalmau, J.2
Sevilla, T.3
Burgal, M.4
Beltran, E.5
Bataller, L.6
-
50
-
-
80055091667
-
Analysis of relapses in anti-NMDAR encephalitis
-
21865579 10.1212/WNL.0b013e31822cfc6b 1:STN:280:DC%2BC3Mfht1yqsA%3D%3D
-
Gabilondo I, Saiz A, Galan L, et al. Analysis of relapses in anti-NMDAR encephalitis. Neurology. 2011;77(10):996-9.
-
(2011)
Neurology
, vol.77
, Issue.10
, pp. 996-999
-
-
Gabilondo, I.1
Saiz, A.2
Galan, L.3
-
51
-
-
69249106795
-
Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents
-
19670433 10.1002/ana.21756
-
Florance NR, Davis RL, Lam C, et al. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol. 2009;66(1):11-8.
-
(2009)
Ann Neurol
, vol.66
, Issue.1
, pp. 11-18
-
-
Florance, N.R.1
Davis, R.L.2
Lam, C.3
-
52
-
-
72049088768
-
Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: Case series and characterisation of the antigen
-
19962348 10.1016/S1474-4422(09)70324-2 1:CAS:528:DC%2BC3cXhtFerurY%3D Identification of cell-membrane antibodies against GABA-B receptor in a subset of patients with limbic encephalitis with predominant seizures, amenable to improvement with immunotherapy
-
Lancaster E, Lai M, Peng X, et al. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol. 2010;9(1):67-76. Identification of cell-membrane antibodies against GABA-B receptor in a subset of patients with limbic encephalitis with predominant seizures, amenable to improvement with immunotherapy.
-
(2010)
Lancet Neurol
, vol.9
, Issue.1
, pp. 67-76
-
-
Lancaster, E.1
Lai, M.2
Peng, X.3
-
53
-
-
43249095163
-
Cyclophosphamide for anti-GAD antibody-positive refractory status epilepticus
-
18177354 10.1111/j.1528-1167.2007.01500.x 1:CAS:528:DC%2BD1cXmsV2lsLY%3D
-
Kanter IC, Huttner HB, Staykov D, et al. Cyclophosphamide for anti-GAD antibody-positive refractory status epilepticus. Epilepsia. 2008;49(5):914-20.
-
(2008)
Epilepsia
, vol.49
, Issue.5
, pp. 914-920
-
-
Kanter, I.C.1
Huttner, H.B.2
Staykov, D.3
-
54
-
-
77951536231
-
Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy
-
19817821 10.1111/j.1528-1167.2009.02325.x
-
Liimatainen S, Peltola M, Sabater L, et al. Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy. Epilepsia. 2010;51(5):760-7.
-
(2010)
Epilepsia
, vol.51
, Issue.5
, pp. 760-767
-
-
Liimatainen, S.1
Peltola, M.2
Sabater, L.3
-
55
-
-
77953386122
-
Progress in the management of paraneoplastic neurological disorders
-
21180635 10.1177/1756285609349521
-
Sadeghian H, Vernino S. Progress in the management of paraneoplastic neurological disorders. Ther Adv Neurol Disord. 2010;3(1):43-52.
-
(2010)
Ther Adv Neurol Disord
, vol.3
, Issue.1
, pp. 43-52
-
-
Sadeghian, H.1
Vernino, S.2
-
56
-
-
70249103810
-
Intravenous immunoglobulin therapy for autoimmune diseases
-
19657774 10.1080/08916930902785363 1:CAS:528:DC%2BD1MXhtVKgtbnM
-
Arnson Y, Shoenfeld Y, Amital H. Intravenous immunoglobulin therapy for autoimmune diseases. Autoimmunity. 2009;42(6):553-60.
-
(2009)
Autoimmunity
, vol.42
, Issue.6
, pp. 553-560
-
-
Arnson, Y.1
Shoenfeld, Y.2
Amital, H.3
-
57
-
-
76649086675
-
Immunomodulatory therapies in neurologic critical care
-
19774497 10.1007/s12028-009-9274-0
-
McDaneld LM, Fields JD, Bourdette DN, Bhardwaj A. Immunomodulatory therapies in neurologic critical care. Neurocrit Care. 2010;12(1):132-43.
-
(2010)
Neurocrit Care
, vol.12
, Issue.1
, pp. 132-143
-
-
McDaneld, L.M.1
Fields, J.D.2
Bourdette, D.N.3
Bhardwaj, A.4
-
58
-
-
67349141484
-
Long-lasting remission after rituximab treatment in a case of anti-Hu-associated sensory neuronopathy and gastric pseudoobstruction
-
19139820 10.1007/s11060-008-9787-y 1:CAS:528:DC%2BD1MXmsVClsbg%3D
-
Coret F, Bosca I, Fratalia L, Perez-Griera J, Pascual A, Casanova B. Long-lasting remission after rituximab treatment in a case of anti-Hu-associated sensory neuronopathy and gastric pseudoobstruction. J Neurooncol. 2009;93(3):421-3.
-
(2009)
J Neurooncol
, vol.93
, Issue.3
, pp. 421-423
-
-
Coret, F.1
Bosca, I.2
Fratalia, L.3
Perez-Griera, J.4
Pascual, A.5
Casanova, B.6
-
59
-
-
70349256093
-
Cancer incidence and risk factors after solid organ transplantation
-
19444916 10.1002/ijc.24439 1:CAS:528:DC%2BD1MXhtVGju7fM
-
Vajdic CM, van Leeuwen MT. Cancer incidence and risk factors after solid organ transplantation. Int J Cancer. 2009;125(8):1747-54.
-
(2009)
Int J Cancer
, vol.125
, Issue.8
, pp. 1747-1754
-
-
Vajdic, C.M.1
Van Leeuwen, M.T.2
-
60
-
-
78650908659
-
Does rituximab increase the incidence of infectious complications? A narrative review
-
21074471 10.1016/j.ijid.2010.03.025 1:CAS:528:DC%2BC3MXhslOhtr0%3D
-
Kelesidis T, Daikos G, Boumpas D, Tsiodras S. Does rituximab increase the incidence of infectious complications? A narrative review. Int J Infect Dis. 2011;15(1):e2-16.
-
(2011)
Int J Infect Dis
, vol.15
, Issue.1
, pp. 2-16
-
-
Kelesidis, T.1
Daikos, G.2
Boumpas, D.3
Tsiodras, S.4
-
61
-
-
78651103644
-
Infectious complications associated with immunomodulating biologic agents
-
21236394 10.1016/j.hoc.2010.11.009
-
Koo S, Marty FM, Baden LR. Infectious complications associated with immunomodulating biologic agents. Hematol Oncol Clin North Am. 2011;25(1):117-38.
-
(2011)
Hematol Oncol Clin North Am
, vol.25
, Issue.1
, pp. 117-138
-
-
Koo, S.1
Marty, F.M.2
Baden, L.R.3
-
62
-
-
77949330147
-
Reactivation of hepatitis B virus following rituximab-based regimens: A serious complication in both HBsAg-positive and HBsAg-negative patients
-
19697028 10.1007/s00277-009-0806-7 1:CAS:528:DC%2BC3cXpsVSiug%3D%3D
-
Pei SN, Chen CH, Lee CM, et al. Reactivation of hepatitis B virus following rituximab-based regimens: a serious complication in both HBsAg-positive and HBsAg-negative patients. Ann Hematol. 2010;89(3):255-62.
-
(2010)
Ann Hematol
, vol.89
, Issue.3
, pp. 255-262
-
-
Pei, S.N.1
Chen, C.H.2
Lee, C.M.3
-
63
-
-
77949375380
-
Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies
-
19719397 10.1146/annurev.med.080708.082655 1:CAS:528:DC%2BC3cXisFyls7g%3D
-
Major EO. Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies. Annu Rev Med. 2010;61:35-47.
-
(2010)
Annu Rev Med
, vol.61
, pp. 35-47
-
-
Major, E.O.1
-
64
-
-
77950337482
-
Rituximab-associated infections
-
20350666 10.1053/j.seminhematol.2010.01.002 1:CAS:528: DC%2BC3cXlslemur8%3D
-
Gea-Banacloche JC. Rituximab-associated infections. Semin Hematol. 2010;47(2):187-98.
-
(2010)
Semin Hematol
, vol.47
, Issue.2
, pp. 187-198
-
-
Gea-Banacloche, J.C.1
-
65
-
-
34547416731
-
EBV-associated lymphoproliferative disorder of CNS associated with the use of mycophenolate mofetil
-
17522336 10.1215/15228517-2007-004
-
O'Neill BP, Vernino S, Dogan A, Giannini C. EBV-associated lymphoproliferative disorder of CNS associated with the use of mycophenolate mofetil. Neuro Oncol. 2007;9(3):364-9.
-
(2007)
Neuro Oncol
, vol.9
, Issue.3
, pp. 364-369
-
-
O'Neill, B.P.1
Vernino, S.2
Dogan, A.3
Giannini, C.4
-
66
-
-
81255150498
-
The laboratory of clinical virology in monitoring patients undergoing monoclonal antibody therapy
-
22082209 10.1111/j.1469-0691.2011.03678.x 1:CAS:528: DC%2BC38XmtlWisQ%3D%3D
-
Cavallo R. The laboratory of clinical virology in monitoring patients undergoing monoclonal antibody therapy. Clin Microbiol Infect. 2011;17(12):1781-5.
-
(2011)
Clin Microbiol Infect
, vol.17
, Issue.12
, pp. 1781-1785
-
-
Cavallo, R.1
-
67
-
-
34548435533
-
Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: Systematic review and meta-analysis of randomized controlled trials
-
17803871 10.4065/82.9.1052 1:CAS:528:DC%2BD2sXhtV2rt7%2FI
-
Green H, Paul M, Vidal L, Leibovici L. Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials. Mayo Clin Proc. 2007;82(9):1052-9.
-
(2007)
Mayo Clin Proc
, vol.82
, Issue.9
, pp. 1052-1059
-
-
Green, H.1
Paul, M.2
Vidal, L.3
Leibovici, L.4
-
68
-
-
33644909875
-
Clinically relevant drug interactions with antiepileptic drugs
-
16487217 10.1111/j.1365-2125.2005.02529.x 1:CAS:528:DC%2BD28XislKhsLs%3D
-
Perucca E. Clinically relevant drug interactions with antiepileptic drugs. Br J Clin Pharmacol. 2006;61(3):246-55.
-
(2006)
Br J Clin Pharmacol
, vol.61
, Issue.3
, pp. 246-255
-
-
Perucca, E.1
-
69
-
-
53049104176
-
Pharmacodynamic and pharmacokinetic interactions of psychotropic drugs with antiepileptic drugs
-
18929094 10.1016/S0074-7742(08)00022-6
-
Kanner AM, Gidal BE. Pharmacodynamic and pharmacokinetic interactions of psychotropic drugs with antiepileptic drugs. Int Rev Neurobiol. 2008;83:397-416.
-
(2008)
Int Rev Neurobiol
, vol.83
, pp. 397-416
-
-
Kanner, A.M.1
Gidal, B.E.2
-
70
-
-
79952714383
-
Anti-NMDA receptor encephalitis: Diagnosis, psychiatric presentation, and treatment
-
21368306 10.1176/appi.ajp.2010.10020181
-
Chapman MR, Vause HE. Anti-NMDA receptor encephalitis: diagnosis, psychiatric presentation, and treatment. Am J Psychiatry. 2011;168(3):245-51.
-
(2011)
Am J Psychiatry
, vol.168
, Issue.3
, pp. 245-251
-
-
Chapman, M.R.1
Vause, H.E.2
-
71
-
-
84865134837
-
A multidisciplinary approach to the treatment of anti-NMDA-receptor antibody encephalitis: A case and review of the literature
-
22772674 10.1176/appi.neuropsych.11070151 1:CAS:528:DC%2BC38Xht1ens7zF
-
Mann A, Machado NM, Liu N, Mazin AH, Silver K, Afzal KI. A multidisciplinary approach to the treatment of anti-NMDA-receptor antibody encephalitis: a case and review of the literature. J Neuropsychiatry Clin Neurosci. 2012;24(2):247-54.
-
(2012)
J Neuropsychiatry Clin Neurosci
, vol.24
, Issue.2
, pp. 247-254
-
-
Mann, A.1
MacHado, N.M.2
Liu, N.3
Mazin, A.H.4
Silver, K.5
Afzal, K.I.6
|